A Third Take-Two Form 144, and Our Follow-Up Answered

Yesterday this desk published a prediction it could be marked wrong on. We reported two Take-Two Form 144 sale notices filed on 2 September, said plainly that a Form 144 is a notice of a proposed sale rather than a record that a sale happened, and flagged that a confirming Form 4 would ordinarily be due around 4 September. That was a checkable follow-up with a date on it. Here is the answer. No Form 4 had been filed by either officer as of the close of 3 September, and it is not late, because the deadline is 4 September and the 4 September filing day had not opened when we looked. The clock caveat, which everything below depends on Every fetch in this article ran between 03:00 and 03:07 UTC on 4 September 2026. That is 23:00 to 23:07 Eastern on Wednesday 3 September. EDGAR's 4 September filing day had not opened. No PACER business had occurred on 4 September. So every negative finding here is a statement about the record through the close of 3 September. Not through 4 September. Section 16(a) allows two business days from the transaction date, so for a Tuesday 2 September transaction the deadline is Thursday 4 September, and at our snapshot the window was still open. Nothing here is late, overdue, missed or concealed, and filing agents routinely batch submissions after market close. The correct posture is that the record is incomplete. The new document: a third Form 144 CONFIRMED, primary document, full text retrieved. Fetched from the SEC archives at 2026-09-04T03:00:43Z, HTTP 200, 5,308 bytes. Accession 0001959173-26-006677, acceptance datetime 2026-09-03T09:57:35Z, filed under reporting-person CIK 0001623654. Verbatim from the XML: <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Emerson Daniel P</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold><relationshipToIssuer>Officer</relationshipToIssuer><noOfUnitsSold>744</noOfUnitsSold><aggregateMarketValue>161470.32</aggregateMarketValue><noOfUnitsOutstanding>186980443</noOfUnitsOutstanding><approxSaleDate>09/03/2026</approxSaleDate><securitiesExchangeName>NASDAQ</securitiesExchangeName> And on where the shares came from, verbatim: <acquiredDate>09/01/2026</acquiredDate><natureOfAcquisitionTransaction>Restricted Stock Vesting</natureOfAcquisitionTransaction><nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired><natureOfPayment>Compensation</natureOfPayment> Broker: Fidelity Brokerage Services LLC, Smithfield, Rhode Island. The signature block reads verbatim "/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel P. Emerson". The arithmetic is ours. 161,470.32 divided by 744 is $217.0300 per share exactly. That is a reference price used to compute the notice's estimated aggregate value. It is not a transaction price and it is not proceeds. So batch 44 reported two notices. There are three. Our earlier piece stands as filed; this is an addition to it, not a correction of it. The underlying stock vested on 1 September, which makes this scheduled compensation reaching a vesting date rather than an opportunistic decision to sell. A Form 144 is a notice of a proposed sale. It is not a record that a sale happened. Nothing in this document establishes that the 744 shares were sold, and aggregateMarketValue is an estimate at the time of notice rather than gross proceeds. The evidentiary upgrade, and why we are hedging it hard A Form 144 must list the filer's own sales over the preceding three months. Emerson's 3 September notice contains four such entries, and the fourth is the one batch 44 was waiting on. Verbatim: <saleDate>09/02/2026</saleDate><amountOfSecuritiesSold>917</amountOfSecuritiesSold><grossProceeds>199583.68</grossProceeds> The three earlier entries, verbatim, as a baseline: 8,840 shares on 06/08/2026 for $1,891,760.00; 4,421 shares on 06/15/2026 for $950,515.00; 4,419 shares on 06/16/2026 for $1,016,370.00. That is a later filing by the same person representing that the 2 September transaction occurred. It is a genuine step up from "proposed". And here is the caveat, which belongs in the same breath. The reported gross proceeds of $199,583.68 are byte-identical to the estimated aggregate market value on the 2 September notice, which valued 917 shares at $217.6485 each. Real executions almost never land exactly on a pre-trade estimate to the cent. Two readings are available and these documents cannot choose between them: either the sale executed at precisely the estimated reference price, or the filing agent carried the earlier estimate forward into the past-sales table. LABEL: CONFIRMED as to what the document says. WEAK as to whether the sale executed. A past-sales table on a Form 144 is a broker and filer representation. It is not an SEC finding and it is not a Form 4. One thing that is unambiguous. Goldstein's proposed sale of 1,335 shares has no corroboration of any kind. She filed nothing on 3 September, so nothing has been added to the record about it. Do not write that her sale executed, because nothing in the public record says it did. The 10b5-1 plan date that appears on one notice and not the others CONFIRMED by direct comparison of three primary documents. The 3 September notice carries, verbatim: <planAdoptionDates>  <planAdoptionDate>03/03/2026</planAdoptionDate></planAdoptionDates> The two 2 September notices, fetched at 03:01:32Z, HTTP 200, at 3,594 bytes and 5,361 bytes respectively, contain no plan adoption date at all. A programmatic check on both returned "planAdoption present: False", and our researcher reproduced both complete signature blocks with nothing elided to prove the field is simply not there. Why this matters. A plan adoption date of 3 March 2026 puts the trading instructions in place roughly six months before the 3 September sale and more than eight months before 19 November. Trades made under a pre-established written plan are, by design, not timed on contemporaneous knowledge. Any framing along the lines of "executives are dumping stock before GTA 6" has to contend with that document. But only for that one notice, and we are being strict about this. The 3 March date is disclosed on one notice, covering one proposed sale, by one officer. It does not establish that Goldstein's 2 September sale, or Emerson's own 2 September sale, was made under any plan. Those two notices state no plan adoption date, and we do not know why. Absence of a disclosure is not a disclosure of absence. We report the difference between the documents and we are not going to explain it, because explaining it would mean inventing a reason. Worth adding as context rather than as exculpation: all of these notices describe the shares as Restricted Stock Vesting from the Issuer as Compensation. Selling at vest is routine and frequently automatic. We are not characterising anybody's intent. The Form 4 check, done four ways, and the trap in it CONFIRMED NEGATIVE, through the close of 3 September. Issuer submissions feed for CIK 0000946581, fetched 03:00:21Z, HTTP 200, 157,862 bytes. Most recent Form 4s are three on 18 August 2026 and one on 11 August. Nothing since. An independent EDGAR endpoint, the browse-edgar Atom feed, fetched 03:06:25Z, HTTP 200. Same answer: latest Form 4 is 18 August 2026. Emerson's own reporting-person CIK, 0001623654, fetched 03:06:49Z, HTTP 200. His last Form 4 of any kind is 18 June 2026. His June pattern was tight: a 144 on the 8th followed by a Form 4 on the 10th, a 144 on the 15th followed by a Form 4 the same day, a 144 on the 16th followed by a Form 4 on the 18th. Goldstein's own reporting-person CIK, 0001399513, fetched 03:07:09Z, HTTP 200, 22,266 bytes. Her last Form 4 is 3 August 2026, and her pattern is next-day: a 144 on 2 March followed by a Form 4 on 3 March, a 144 on 2 June followed by a Form 4 on 3 June. THE METHODOLOGICAL CATCH, and this one changes how we check in future. Goldstein's Form 4s dated 3 August, 26 June, 4 May and 2 February 2026 were filed under filing-agent accession prefix 0001412408, and they do not appear in Take-Two's issuer submissions feed at all. That feed jumps straight from 18 August to 11 August to 6 July. Checking the issuer CIK alone will therefore miss Section 16 filings and report a false negative. Batch 44's expectation was sound; the verification method was not, and the fix is to query the reporting persons' own CIKs directly, which is what produced the four-way check above. We are printing this because a reader running the same check tomorrow deserves to know where the hole is. The next genuinely newsworthy checkpoint is a re-query of both CIKs after 4 September's EDGAR close. If no Form 4 exists after that, the characterisation changes. Only then, and only on evidence. Corporate disclosure silence, and a cross-source agreement CONFIRMED NEGATIVE. Take-Two's complete list of issuer filings since 20 August is three items, all Form 144. No 8-K, no 10-Q, no S-8, no proxy material, no registration statement, no Schedule 13. The last 8-K and 10-Q were both filed on 7 August 2026, so there has been no Take-Two 8-K in 28 days. With the game dated 19 November, a release-date change would ordinarily surface as an 8-K or a furnished press release. None exists in this window. A small cross-source agreement worth one line: the Form 144 reports 186,980,443 shares outstanding, which corroborates the roughly 186.98 million share count reported by market-data vendors. Two independent kinds of source landing on the same figure is worth noting when so much else here disagrees. TTWO on 3 September, with the disagreement printed rather than resolved The close is unanimous. Both sources report $214.13, down $2.01, 0.93 per cent, at the close of 3 September 2026. Use it with confidence. The volume is not. Three endpoints, two vendors, three different numbers for the same session: SourceVolume, 3 September 2026Fetched Nasdaq quote endpoint2,710,83303:00:23Z Nasdaq historical endpoint2,710,79703:05:47Z stockanalysis.com2,710,79303:05:37Z Forty shares between highest and lowest, which is trivial against 2.71 million. We print it anyway, and the useful detail is that Nasdaq disagrees with itself: two endpoints operated by the same vendor return different numbers for the same session. If you see two articles quoting different volumes, they are not necessarily in conflict, and a volume figure should always carry the name of the source that produced it. The honest short form is "approximately 2.71 million shares, and vendors differ in the final digits". The wider series, from the Nasdaq historical endpoint at 03:05:47Z, HTTP 200: DateCloseVolumeOpenHighLow 03/09/2026$214.132,710,797$216.96$220.583$213.60 02/09/2026$216.142,488,205$216.06$220.7099$214.85 01/09/2026$216.682,802,340$217.01$219.5399$214.14 31/08/2026$219.706,853,654$233.56$234.565$216.759 28/08/2026$235.393,711,409$239.00$240.54$232.15 27/08/2026$233.004,228,057$234.90$238.25$225.10 26/08/2026$233.452,171,662$232.58$241.2878$232.48 25/08/2026$232.931,593,502$233.50$237.49$232.44 Our own arithmetic on those rows. From the 28 August close of $235.39 to the 3 September close of $214.13 the shares fell $21.26, or 9.03 per cent, across four sessions. The single largest session was 31 August, when the stock opened at $233.56 and closed at $219.70, a fall of $15.69 or 6.67 per cent from the previous close, on 6,853,654 shares, roughly 4.3 times the 25 August volume and by a wide margin the heaviest day in the series. Volume has since normalised to around 2.5 to 2.8 million, back in the pre-31-August range, so the heavy-volume event was one day and has not persisted. The 3 September intraday low of $213.60 is the lowest low in this series, but the 52-week low remains $187.63, so the stock is not at a 52-week low. After hours on 3 September the quote was $214.55, up $0.42, at 7:59 p.m. Eastern. The causation rule, which is not optional A price move is a fact. Its cause is inference. Nothing in this article attributes any part of that decline to GTA 6 news, to the DMCA subpoenas, to officer sale notices, to a leak, to an analyst action or to anything else. 6Charts has not established a cause for the move. There is also an ordering problem worth stating explicitly, because it rules out the most tempting story. The 31 August move preceded the 2 and 3 September Form 144 notices, so those notices cannot have caused it. And the notices cover restricted stock that vested on 1 September, which is a compensation schedule rather than a market view. We are not asserting the reverse either. We are stating the numbers and stopping. What is and is not established CONFIRMED, from EDGAR: a third Form 144, accession 0001959173-26-006677, accepted 2026-09-03T09:57:35Z, for 744 shares at an estimated $161,470.32, covering stock that vested 1 September 2026 by Restricted Stock Vesting. CONFIRMED by our own arithmetic: $161,470.32 divided by 744 is $217.0300 exactly, a reference price rather than a transaction price. CONFIRMED as to the document, WEAK as to execution: the 3 September notice lists the 2 September sale of 917 shares at $199,583.68 in its past-three-months table, but that figure is identical to the prior notice's estimate, which is not how real executions usually land. No corroboration whatsoever: Goldstein's proposed sale of 1,335 shares. Nothing has been added to the record about it. CONFIRMED: a Rule 10b5-1 plan adoption date of 03/03/2026 appears on the 3 September notice and is absent from both 2 September notices. That defuses a "selling before launch" reading for that one notice only, and absence of a disclosure is not a disclosure of absence. CONFIRMED NEGATIVE, through the close of 3 September: no confirming Form 4 from either officer, verified on the issuer feed, an independent EDGAR endpoint and both reporting persons' own CIKs. Not late. The deadline is 4 September and that filing day had not opened at our snapshot. METHOD CORRECTION for future checks: Form 4s filed under agent CIK 0001412408 do not appear in the issuer feed, so an issuer-CIK-only check returns a false negative. Query CIK 0001623654 and CIK 0001399513 directly. CONFIRMED NEGATIVE: no Take-Two 8-K since 7 August 2026, and only three Form 144 notices on the issuer feed since 20 August. CONFIRMED, and the disagreement printed rather than resolved: the close of $214.13 is unanimous; volume for the same session is reported as 2,710,833, 2,710,797 and 2,710,793, with two of those from the same vendor. Explicitly not claimed: any cause for any price move, and any sale by any person. A Form 144 is a notice of a proposed sale. Named because they are corporate officers who filed under their own names with the SEC: Daniel P. Emerson and Lainie Goldstein. No individual from any court exhibit is named anywhere on this desk. Our earlier work on the 31 August session and on 10b5-1 mechanics sets the context for all of this, and the running record of what Take-Two has actually put on paper is on the wiki. Nothing here is financial advice, nothing here establishes that anybody did anything wrong, and the rest of today's reporting is on the news desk.